This book covers the role of statins in all cardiovascular ailments, from prevention to disease management, and brought you the evolving pharmacological interventions. It is an attempt to interference with the cholesterol synthesis pathways through statins and bempedoic acid, and blocking PCSK9 from binding to LDL receptor by intercepting with antibodies or nipping them early by intracellular inhibition of the translation of message to proteins, the monograph brings into focus the ultimate importance of LDL receptors.